Projects per year
Personal profile
Personal profile
Dr. Kai Sun received her Bachelor of Science in Medicine and Master of Science in Medicine from Medical College of Qingdao University. She completed her Internal Medicine Residency at Houston Methodist Hospital. Dr. Sun then completed Hematology and Oncology Fellowship at Houston Methodist Hospital and served as the Chief Fellow.
Research interests
Dr Sun has a special interest in treating breast cancer. Her research interests include participation in clinical trials and research in obesity associated breast cancer.
External positions
Assistant Professor of Medicine, Weill Cornell Medical College
Apr 1 2023 → …
Research Area Keywords
- Cancer
- Clinical Care
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Kai Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 14 Article
-
1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C., Gee, K., Burns, E. A., Xu, J., Zhang, Y., Crenshaw, A., Esmail, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Efstathiou, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1360-A1360Research output: Contribution to journal › Article › peer-review
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K., Wiechmann, C., Burns, E. A., Xu, J., Zhang, Y., Esmail, A., Crenshaw, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1361-A1361Research output: Contribution to journal › Article › peer-review
-
451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
Xu, J., Burns, E. A., Gee, K., Wiechmann, C., Zhang, Y., Kieser, R. B., Umoru, G., Shah, S., Sun, K., Abdelrahim, M. & Esmail, A., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A502-A502Research output: Contribution to journal › Article › peer-review
-
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J., Sun, K., Guerrero, C. A., Zheng, J., Xu, Y., Mathur, S., Teh, B. S., Farach, A., Zhang, J., Butler, E., Pan, P. Y., Zsigmond, E., Mei, Z., Mejia, J., Chen, S. H., Chang, J. C. & Bernicker, E. H., Aug 24 2023, (E-pub ahead of print) In: International Journal of Radiation Oncology Biology Physics. 118, 5, p. 1531-1540 10 p.Research output: Contribution to journal › Article › peer-review
-
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer
Sun, K., Xu, Y., Mathur, S., Bernicker, E. H. & Chang, J. C., 2023, (Unpublished) In: Clinical Cancer Research. 25 p.Research output: Contribution to journal › Article › peer-review